Pharmafile Logo

Gower Publishing

- PMLiVE

Gilead makes a play for novel cancer drug with Tizona deal

Pharma company continues oncology biotech spending spree

Onyx Health Expands with New Management Appointment

Onyx Health have continued to grow throughout the COVID-19 downturn and have expanded the agency further by appointing Alix Stonehouse as their new Account Manager

Onyx Health

- PMLiVE

China’s CanSino Biologics reveals phase 2 coronavirus vaccine results

Candidate induced neutralising antibody responses

- PMLiVE

Novartis stumbles in Q2 as COVID-19 impacts sales

Net profit drops by 4% as pandemic hits sales

AstraZeneca AZ

AZ/Oxford’s COVID-19 vaccine proves promising in early trials

Vaccine candidate produced robust immune response

- PMLiVE

Media Means Business

Creating meaningful media experiences in pharma

Havas Lynx

- PMLiVE

UK agrees further COVID-19 vaccine deals with Pfizer/BioNTech, Valneva

Government has already agreed similar deal with AstraZeneca

Top 5 tips for a multi-indication product launch

Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.

Blue Latitude Health

- PMLiVE

UK biotech Synairgen reveals promising early results for COVID-19 drug

Phase 1 results show drug cuts risk of developing severe disease by 79%

- PMLiVE

GSK agrees on 10% equity stake in mRNA specialist CureVac

Equity investment totals £130m with an upfront payment of £104m

National Educational Webcast on Virtual Care: a Customer Story

Learn how our client used Impetus Digital's virtual tools and services to develop and execute a national educational webinar on telehealth.

Impetus Digital

If our patients are diverse, why are clinical trials so white?

Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue...

Blue Latitude Health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links